- Home
- NSPR vs ASRT Comparison
NSPR vs ASRT Comparison
Compare NSPR & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NSPR | ASRT |
|---|---|---|
| Founded | 2005 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.8M | 75.1M |
| IPO Year | N/A | 1997 |
Fundamental Metrics
Financial Performance| Metric | NSPR | ASRT |
|---|---|---|
| Price | $1.95 | $0.73 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $4.00 | $3.00 |
| AVG Volume (30 Days) | 84.2K | ★ 313.9K |
| Earning Date | 11-04-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $7,779,000.00 | ★ $137,354,000.00 |
| Revenue This Year | $22.76 | N/A |
| Revenue Next Year | $75.45 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 14.04 | 9.22 |
| 52 Week Low | $1.59 | $0.51 |
| 52 Week High | $3.80 | $1.01 |
Technical Indicators
Market Signals| Indicator | NSPR | ASRT |
|---|---|---|
| Relative Strength Index (RSI) | 48.95 | 41.47 |
| Support Level | $1.88 | $0.75 |
| Resistance Level | $2.07 | $0.80 |
| Average True Range (ATR) | 0.12 | 0.04 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 62.89 | 23.22 |
Price Performance
Historical ComparisonAbout NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.